万辰集团 (300972)

Fujian Wanchen Biotechnology Group Co.,Ltd.

ASZ

Tags

IP EconomyRural RevitalizationGuozheng Growth IndexSmall Cap GrowthNewly Added ConstituentsWest Coast of the Taiwan StraitHundred-Yuan StocksHigh-Performing StocksEquity TransferMargin Trading and Securities LendingIndustry LeadersRestructuring StocksRetailHigh Price-to-Book RatioChiNext 300 IndexChiNext IndexSZSE 300 IndexSZSE Growth Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 18889.14
  • Circulating A-Shares(W): 16799.31
  • Earnings Per Share(RMB): 4.6840
  • Net Assets Per Share(RMB): 10.8827
  • Operating Revenue(W RMB): 3656231.05
  • Total Profit(W RMB): 216024.20
  • Net Profit Attributable to Parent(W RMB): 85497.84
  • Net Profit Growth Rate(%): 917.04
  • Weighted Return on Equity(%): 54.2600
  • Operating Cash Flow Per Share(RMB): 12.6950
  • Undistributed Profit Per Share(RMB): 6.0186
  • Capital Reserve Per Share(RMB): 3.6553

2. Main Business

The main business covers:

  • Bulk Snack Business
  • Edible Fungus Business

3. Company Basic Information

  • Company Name: Fujian Wanchen Biotechnology Group Co., Ltd.
  • Listing Date: 2021-04-19
  • Industry: Retail
  • Address: Zhangpu Taiwan Farmers’ Entrepreneurship Park, Fujian Province
  • Website: www.vanchen.com
  • Company Profile: On May 26, 2014, Wanchen Co., Ltd. held a shareholders' meeting and agreed to change the enterprise type of Wanchen Co., Ltd. to a joint stock company, using March 31, 2014 as the evaluation benchmark date. Grant Thornton (Special General Partnership) audited the financial report of Wanchen Co., Ltd. and issued the "Grant Thornton Audit [2014] No. 350ZA1614" Audit Report, confirming that as of March 31, 2014, the net assets of Wanchen Co., Ltd. were 93.7903 million yuan. Xiamen University Assets Appraisal Co., Ltd. appraised the audited assets and liabilities of Wanchen Co., Ltd. and issued the "University Appraisal [2014] ZL0010" Asset Appraisal Report, confirming that the assessed value of the net assets of Wanchen Co., Ltd. as of March 31, 2014 was 120.9539 million yuan. On May 26, 2014, all shareholders of Wanchen Co., Ltd., Fujian Agricultural Development, Zhangzhou Jinwanchen Investment Co., Ltd., and Wang Zening signed the "Sponsor Agreement for the Establishment of Fujian Wanchen Biotechnology Co., Ltd.", stipulating that the audited net assets of Wanchen Co., Ltd. as of March 31, 2014, amounting to 93.7903 million yuan, would be converted into 69 million shares, with the remaining net assets of 24.7903 million yuan being included in capital reserve. Grant Thornton (Special General Partnership) verified the capital contribution of all shareholders of the company and issued the "Grant Thornton Verification (2014) No. 350ZA0094" Capital Verification Report, confirming that "As of June 10, 2014, the company used the audited net assets of RMB 93,790,333.44 as of March 31, 2014 to convert RMB 69,000,000.00 into registered capital, and the remainder was included in capital reserve." On June 27, 2014, the company completed the industrial and commercial registration and obtained the Business License with the registration number "350623100034968".

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Fujian Mimosa Agricultural Development Co., Ltd. General Legal Person 3275.92 19.64
2 Zhangzhou Jinwanchen Investment Co., Ltd. General Legal Person 2465.78 14.78
3 Shenzhen Dingxin Enterprise Consulting Management Co., Ltd. General Legal Person 433.78 2.60
4 Hong Kong Securities Clearing Company Ltd. Northbound Funds 374.04 2.24
5 Orient Hong Kong QHeng 3-Year Holding Hybrid Securities Investment Fund A Fund 266.84 1.60
6 Orient Hong Kong Qidong 3-Year Holding Hybrid Securities Investment Fund Fund 199.29 1.19
7 Orient Hong Kong Ruihe 3-Year Holding Hybrid Securities Investment Fund A Fund 57.57 0.35
8 Zhong Ou Jingqi Jingxuan Hybrid Securities Investment Fund A Fund 55.40 0.33
9 Haitong Growth Value Hybrid Securities Investment Fund A Fund 46.55 0.28
10 Orient Hong Kong Qihang 3-Year Holding Hybrid Securities Investment Fund A Fund 43.35 0.26

5. Concept Sectors

  • West Coast of the Taiwan Strait
  • Rural Revitalization
  • IP Economy
  • Margin Trading & Securities Lending
  • High Price-to-Book Ratio
  • Blue-Chip Stock
  • Industry Leader
  • Equity Transfer
  • Hundred-Yuan Stock
  • Restructuring Stock
  • Newly Added Constituent
  • ChiNext Index
  • Small-Cap Growth
  • SZSE 300 Index
  • SZSE Growth Index
  • SZSE Growth
  • ChiNext 300
  • ChiNext Growth
  • ChiNext Quality

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information